ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXL1
|
ENSG00000176678.4 | FOXL1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXL1 | hg19_v2_chr16_+_86612112_86612123 | 0.05 | 8.7e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_8543393 | 5.61 |
ENST00000157600.3 ENST00000415597.1 ENST00000535732.1 |
LMCD1 |
LIM and cysteine-rich domains 1 |
chr3_+_157154578 | 5.39 |
ENST00000295927.3 |
PTX3 |
pentraxin 3, long |
chr13_-_38172863 | 4.75 |
ENST00000541481.1 ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN |
periostin, osteoblast specific factor |
chr2_-_151344172 | 4.75 |
ENST00000375734.2 ENST00000263895.4 ENST00000454202.1 |
RND3 |
Rho family GTPase 3 |
chr7_+_134528635 | 4.54 |
ENST00000445569.2 |
CALD1 |
caldesmon 1 |
chr3_+_8543561 | 3.42 |
ENST00000397386.3 |
LMCD1 |
LIM and cysteine-rich domains 1 |
chr2_+_189839046 | 3.02 |
ENST00000304636.3 ENST00000317840.5 |
COL3A1 |
collagen, type III, alpha 1 |
chr3_+_8543533 | 2.90 |
ENST00000454244.1 |
LMCD1 |
LIM and cysteine-rich domains 1 |
chr12_-_91574142 | 2.77 |
ENST00000547937.1 |
DCN |
decorin |
chr4_+_169418195 | 2.75 |
ENST00000261509.6 ENST00000335742.7 |
PALLD |
palladin, cytoskeletal associated protein |
chr12_-_91573249 | 2.48 |
ENST00000550099.1 ENST00000546391.1 ENST00000551354.1 |
DCN |
decorin |
chr10_-_95241951 | 2.22 |
ENST00000358334.5 ENST00000359263.4 ENST00000371488.3 |
MYOF |
myoferlin |
chr10_-_95242044 | 2.21 |
ENST00000371501.4 ENST00000371502.4 ENST00000371489.1 |
MYOF |
myoferlin |
chr12_-_91572278 | 2.16 |
ENST00000425043.1 ENST00000420120.2 ENST00000441303.2 ENST00000456569.2 |
DCN |
decorin |
chr3_-_127455200 | 2.13 |
ENST00000398101.3 |
MGLL |
monoglyceride lipase |
chr7_+_134430212 | 2.13 |
ENST00000436461.2 |
CALD1 |
caldesmon 1 |
chr11_+_133938955 | 2.11 |
ENST00000534549.1 ENST00000441717.3 |
JAM3 |
junctional adhesion molecule 3 |
chr3_-_149095652 | 2.04 |
ENST00000305366.3 |
TM4SF1 |
transmembrane 4 L six family member 1 |
chr11_+_133938820 | 2.03 |
ENST00000299106.4 ENST00000529443.2 |
JAM3 |
junctional adhesion molecule 3 |
chr9_+_112810878 | 1.91 |
ENST00000434623.2 ENST00000374525.1 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
chr2_+_102928009 | 1.86 |
ENST00000404917.2 ENST00000447231.1 |
IL1RL1 |
interleukin 1 receptor-like 1 |
chr11_+_114168085 | 1.81 |
ENST00000541754.1 |
NNMT |
nicotinamide N-methyltransferase |
chr5_+_140749803 | 1.78 |
ENST00000576222.1 |
PCDHGB3 |
protocadherin gamma subfamily B, 3 |
chr12_-_91573316 | 1.75 |
ENST00000393155.1 |
DCN |
decorin |
chr4_+_169418255 | 1.75 |
ENST00000505667.1 ENST00000511948.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr12_-_91546926 | 1.53 |
ENST00000550758.1 |
DCN |
decorin |
chr6_-_132272504 | 1.53 |
ENST00000367976.3 |
CTGF |
connective tissue growth factor |
chr10_-_91011548 | 1.50 |
ENST00000456827.1 |
LIPA |
lipase A, lysosomal acid, cholesterol esterase |
chr9_-_117853297 | 1.42 |
ENST00000542877.1 ENST00000537320.1 ENST00000341037.4 |
TNC |
tenascin C |
chr13_+_73629107 | 1.41 |
ENST00000539231.1 |
KLF5 |
Kruppel-like factor 5 (intestinal) |
chr14_+_22458631 | 1.37 |
ENST00000390444.1 |
TRAV16 |
T cell receptor alpha variable 16 |
chr5_+_140739537 | 1.35 |
ENST00000522605.1 |
PCDHGB2 |
protocadherin gamma subfamily B, 2 |
chr1_+_21880560 | 1.35 |
ENST00000425315.2 |
ALPL |
alkaline phosphatase, liver/bone/kidney |
chr9_-_21335240 | 1.33 |
ENST00000537938.1 |
KLHL9 |
kelch-like family member 9 |
chr7_-_93520259 | 1.31 |
ENST00000222543.5 |
TFPI2 |
tissue factor pathway inhibitor 2 |
chr11_+_35211511 | 1.30 |
ENST00000524922.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr1_+_163038565 | 1.30 |
ENST00000421743.2 |
RGS4 |
regulator of G-protein signaling 4 |
chr4_-_100242549 | 1.30 |
ENST00000305046.8 ENST00000394887.3 |
ADH1B |
alcohol dehydrogenase 1B (class I), beta polypeptide |
chr11_-_104817919 | 1.28 |
ENST00000533252.1 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
chr9_-_35691017 | 1.27 |
ENST00000378292.3 |
TPM2 |
tropomyosin 2 (beta) |
chr19_-_44031375 | 1.25 |
ENST00000292147.2 |
ETHE1 |
ethylmalonic encephalopathy 1 |
chr9_-_14180778 | 1.25 |
ENST00000380924.1 ENST00000543693.1 |
NFIB |
nuclear factor I/B |
chr6_+_121756809 | 1.20 |
ENST00000282561.3 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
chr3_-_99833333 | 1.19 |
ENST00000354552.3 ENST00000331335.5 ENST00000398326.2 |
FILIP1L |
filamin A interacting protein 1-like |
chr6_-_169654139 | 1.18 |
ENST00000366787.3 |
THBS2 |
thrombospondin 2 |
chr12_+_75874984 | 1.17 |
ENST00000550491.1 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr3_-_165555200 | 1.17 |
ENST00000479451.1 ENST00000540653.1 ENST00000488954.1 ENST00000264381.3 |
BCHE |
butyrylcholinesterase |
chr8_+_30244580 | 1.16 |
ENST00000523115.1 ENST00000519647.1 |
RBPMS |
RNA binding protein with multiple splicing |
chr1_+_163039143 | 1.16 |
ENST00000531057.1 ENST00000527809.1 ENST00000367908.4 |
RGS4 |
regulator of G-protein signaling 4 |
chr11_+_35201826 | 1.13 |
ENST00000531873.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr8_-_18666360 | 1.13 |
ENST00000286485.8 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
chr8_+_26247878 | 1.12 |
ENST00000518611.1 |
BNIP3L |
BCL2/adenovirus E1B 19kDa interacting protein 3-like |
chrX_-_10645773 | 1.11 |
ENST00000453318.2 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
chr2_+_201450591 | 1.11 |
ENST00000374700.2 |
AOX1 |
aldehyde oxidase 1 |
chr9_-_21335356 | 1.07 |
ENST00000359039.4 |
KLHL9 |
kelch-like family member 9 |
chr1_-_173174681 | 1.07 |
ENST00000367718.1 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
chr1_+_145524891 | 1.06 |
ENST00000369304.3 |
ITGA10 |
integrin, alpha 10 |
chr7_+_80275953 | 1.02 |
ENST00000538969.1 ENST00000544133.1 ENST00000433696.2 |
CD36 |
CD36 molecule (thrombospondin receptor) |
chr1_-_227505289 | 1.00 |
ENST00000366765.3 |
CDC42BPA |
CDC42 binding protein kinase alpha (DMPK-like) |
chrX_+_135251783 | 1.00 |
ENST00000394153.2 |
FHL1 |
four and a half LIM domains 1 |
chr2_-_163099885 | 0.99 |
ENST00000443424.1 |
FAP |
fibroblast activation protein, alpha |
chr7_-_93520191 | 0.99 |
ENST00000545378.1 |
TFPI2 |
tissue factor pathway inhibitor 2 |
chr1_+_78470530 | 0.99 |
ENST00000370763.5 |
DNAJB4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
chr3_-_149293990 | 0.99 |
ENST00000472417.1 |
WWTR1 |
WW domain containing transcription regulator 1 |
chr3_+_159557637 | 0.98 |
ENST00000445224.2 |
SCHIP1 |
schwannomin interacting protein 1 |
chr12_+_58087901 | 0.98 |
ENST00000315970.7 ENST00000547079.1 ENST00000439210.2 ENST00000389146.6 ENST00000413095.2 ENST00000551035.1 ENST00000257966.8 ENST00000435406.2 ENST00000550372.1 ENST00000389142.5 |
OS9 |
osteosarcoma amplified 9, endoplasmic reticulum lectin |
chr3_-_114035026 | 0.97 |
ENST00000570269.1 |
RP11-553L6.5 |
RP11-553L6.5 |
chr9_-_13175823 | 0.96 |
ENST00000545857.1 |
MPDZ |
multiple PDZ domain protein |
chr12_-_91573132 | 0.95 |
ENST00000550563.1 ENST00000546370.1 |
DCN |
decorin |
chr9_-_79307096 | 0.95 |
ENST00000376717.2 ENST00000223609.6 ENST00000443509.2 |
PRUNE2 |
prune homolog 2 (Drosophila) |
chr3_+_158787041 | 0.94 |
ENST00000471575.1 ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
chr7_-_80551671 | 0.92 |
ENST00000419255.2 ENST00000544525.1 |
SEMA3C |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
chr1_-_150780757 | 0.87 |
ENST00000271651.3 |
CTSK |
cathepsin K |
chr8_+_97506033 | 0.86 |
ENST00000518385.1 |
SDC2 |
syndecan 2 |
chr6_-_52859046 | 0.86 |
ENST00000457564.1 ENST00000541324.1 ENST00000370960.1 |
GSTA4 |
glutathione S-transferase alpha 4 |
chr11_-_104840093 | 0.86 |
ENST00000417440.2 ENST00000444739.2 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
chr17_-_7145475 | 0.85 |
ENST00000571129.1 ENST00000571253.1 ENST00000573928.1 |
GABARAP |
GABA(A) receptor-associated protein |
chr1_+_84630645 | 0.85 |
ENST00000394839.2 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chrX_+_54834791 | 0.85 |
ENST00000218439.4 ENST00000375058.1 ENST00000375060.1 |
MAGED2 |
melanoma antigen family D, 2 |
chr9_+_75766652 | 0.83 |
ENST00000257497.6 |
ANXA1 |
annexin A1 |
chr2_+_152214098 | 0.79 |
ENST00000243347.3 |
TNFAIP6 |
tumor necrosis factor, alpha-induced protein 6 |
chr11_-_104827425 | 0.78 |
ENST00000393150.3 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
chr3_-_158390282 | 0.78 |
ENST00000264265.3 |
LXN |
latexin |
chr19_-_43382142 | 0.78 |
ENST00000597058.1 |
PSG1 |
pregnancy specific beta-1-glycoprotein 1 |
chr11_+_5710919 | 0.77 |
ENST00000379965.3 ENST00000425490.1 |
TRIM22 |
tripartite motif containing 22 |
chr7_+_80275752 | 0.77 |
ENST00000419819.2 |
CD36 |
CD36 molecule (thrombospondin receptor) |
chr16_+_14802801 | 0.77 |
ENST00000526520.1 ENST00000531598.2 |
NPIPA3 |
nuclear pore complex interacting protein family, member A3 |
chr11_+_12766583 | 0.77 |
ENST00000361985.2 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr17_-_76899275 | 0.76 |
ENST00000322630.2 ENST00000586713.1 |
DDC8 |
Protein DDC8 homolog |
chr4_-_186877806 | 0.76 |
ENST00000355634.5 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr1_+_81771806 | 0.75 |
ENST00000370721.1 ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2 |
latrophilin 2 |
chr1_-_110933611 | 0.75 |
ENST00000472422.2 ENST00000437429.2 |
SLC16A4 |
solute carrier family 16, member 4 |
chr2_-_188419200 | 0.75 |
ENST00000233156.3 ENST00000426055.1 ENST00000453013.1 ENST00000417013.1 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr5_-_111093759 | 0.74 |
ENST00000509979.1 ENST00000513100.1 ENST00000508161.1 ENST00000455559.2 |
NREP |
neuronal regeneration related protein |
chr12_+_75874580 | 0.74 |
ENST00000456650.3 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr9_-_21995300 | 0.74 |
ENST00000498628.2 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr12_+_26348246 | 0.74 |
ENST00000422622.2 |
SSPN |
sarcospan |
chrX_+_135252050 | 0.73 |
ENST00000449474.1 ENST00000345434.3 |
FHL1 |
four and a half LIM domains 1 |
chr1_-_89591749 | 0.72 |
ENST00000370466.3 |
GBP2 |
guanylate binding protein 2, interferon-inducible |
chr8_+_97597148 | 0.70 |
ENST00000521590.1 |
SDC2 |
syndecan 2 |
chr1_+_73771844 | 0.67 |
ENST00000440762.1 ENST00000444827.1 ENST00000415686.1 ENST00000411903.1 |
RP4-598G3.1 |
RP4-598G3.1 |
chr2_+_172544294 | 0.66 |
ENST00000358002.6 ENST00000435234.1 ENST00000443458.1 ENST00000412370.1 |
DYNC1I2 |
dynein, cytoplasmic 1, intermediate chain 2 |
chr3_-_79816965 | 0.66 |
ENST00000464233.1 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr6_-_112575912 | 0.66 |
ENST00000522006.1 ENST00000230538.7 ENST00000519932.1 |
LAMA4 |
laminin, alpha 4 |
chr1_-_79472365 | 0.65 |
ENST00000370742.3 |
ELTD1 |
EGF, latrophilin and seven transmembrane domain containing 1 |
chr12_-_30887948 | 0.65 |
ENST00000433722.2 |
CAPRIN2 |
caprin family member 2 |
chr2_+_172544011 | 0.64 |
ENST00000508530.1 |
DYNC1I2 |
dynein, cytoplasmic 1, intermediate chain 2 |
chr3_-_38691119 | 0.63 |
ENST00000333535.4 ENST00000413689.1 ENST00000443581.1 ENST00000425664.1 ENST00000451551.2 |
SCN5A |
sodium channel, voltage-gated, type V, alpha subunit |
chr2_-_188419078 | 0.63 |
ENST00000437725.1 ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr10_-_75415825 | 0.63 |
ENST00000394810.2 |
SYNPO2L |
synaptopodin 2-like |
chr4_+_90823130 | 0.62 |
ENST00000508372.1 |
MMRN1 |
multimerin 1 |
chr11_-_117166276 | 0.62 |
ENST00000510630.1 ENST00000392937.6 |
BACE1 |
beta-site APP-cleaving enzyme 1 |
chr4_+_26585538 | 0.62 |
ENST00000264866.4 |
TBC1D19 |
TBC1 domain family, member 19 |
chr7_-_41742697 | 0.61 |
ENST00000242208.4 |
INHBA |
inhibin, beta A |
chr12_-_90024360 | 0.60 |
ENST00000393164.2 |
ATP2B1 |
ATPase, Ca++ transporting, plasma membrane 1 |
chr7_+_55177416 | 0.59 |
ENST00000450046.1 ENST00000454757.2 |
EGFR |
epidermal growth factor receptor |
chr5_+_140797296 | 0.59 |
ENST00000398594.2 |
PCDHGB7 |
protocadherin gamma subfamily B, 7 |
chr3_+_138066539 | 0.59 |
ENST00000289104.4 |
MRAS |
muscle RAS oncogene homolog |
chr5_-_16738451 | 0.58 |
ENST00000274203.9 ENST00000515803.1 |
MYO10 |
myosin X |
chr12_+_16109519 | 0.58 |
ENST00000526530.1 |
DERA |
deoxyribose-phosphate aldolase (putative) |
chr3_+_187930719 | 0.58 |
ENST00000312675.4 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
chr8_-_18541603 | 0.58 |
ENST00000428502.2 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
chr2_+_54342574 | 0.58 |
ENST00000303536.4 ENST00000394666.3 |
ACYP2 |
acylphosphatase 2, muscle type |
chr1_+_21766641 | 0.57 |
ENST00000342104.5 |
NBPF3 |
neuroblastoma breakpoint family, member 3 |
chr18_+_61554932 | 0.57 |
ENST00000299502.4 ENST00000457692.1 ENST00000413956.1 |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chr14_-_70883708 | 0.56 |
ENST00000256366.4 |
SYNJ2BP |
synaptojanin 2 binding protein |
chr4_+_87515454 | 0.56 |
ENST00000427191.2 ENST00000436978.1 ENST00000502971.1 |
PTPN13 |
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) |
chr5_+_140762268 | 0.56 |
ENST00000518325.1 |
PCDHGA7 |
protocadherin gamma subfamily A, 7 |
chr9_-_95244781 | 0.56 |
ENST00000375544.3 ENST00000375543.1 ENST00000395538.3 ENST00000450139.2 |
ASPN |
asporin |
chr1_+_21766588 | 0.55 |
ENST00000454000.2 ENST00000318220.6 ENST00000318249.5 |
NBPF3 |
neuroblastoma breakpoint family, member 3 |
chr2_+_102927962 | 0.55 |
ENST00000233954.1 ENST00000393393.3 ENST00000410040.1 |
IL1RL1 IL18R1 |
interleukin 1 receptor-like 1 interleukin 18 receptor 1 |
chr20_+_60174827 | 0.55 |
ENST00000543233.1 |
CDH4 |
cadherin 4, type 1, R-cadherin (retinal) |
chr1_+_84630053 | 0.54 |
ENST00000394838.2 ENST00000370682.3 ENST00000432111.1 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chr15_+_23255242 | 0.54 |
ENST00000450802.3 |
GOLGA8I |
golgin A8 family, member I |
chr12_-_10007448 | 0.54 |
ENST00000538152.1 |
CLEC2B |
C-type lectin domain family 2, member B |
chr4_+_55095264 | 0.53 |
ENST00000257290.5 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
chr12_-_50616382 | 0.53 |
ENST00000552783.1 |
LIMA1 |
LIM domain and actin binding 1 |
chr1_+_196621002 | 0.52 |
ENST00000367429.4 ENST00000439155.2 |
CFH |
complement factor H |
chr12_-_102455902 | 0.52 |
ENST00000240079.6 |
CCDC53 |
coiled-coil domain containing 53 |
chr3_+_12392971 | 0.51 |
ENST00000287820.6 |
PPARG |
peroxisome proliferator-activated receptor gamma |
chr11_+_102980126 | 0.51 |
ENST00000375735.2 |
DYNC2H1 |
dynein, cytoplasmic 2, heavy chain 1 |
chr14_+_74035763 | 0.51 |
ENST00000238651.5 |
ACOT2 |
acyl-CoA thioesterase 2 |
chr12_+_133757995 | 0.51 |
ENST00000536435.2 ENST00000228289.5 ENST00000541211.2 ENST00000500625.3 ENST00000539248.2 ENST00000542711.2 ENST00000536899.2 ENST00000542986.2 ENST00000537565.1 ENST00000541975.2 |
ZNF268 |
zinc finger protein 268 |
chr12_-_102455846 | 0.51 |
ENST00000545679.1 |
CCDC53 |
coiled-coil domain containing 53 |
chr1_-_203151933 | 0.51 |
ENST00000404436.2 |
CHI3L1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
chr14_-_107199464 | 0.50 |
ENST00000433072.2 |
IGHV3-72 |
immunoglobulin heavy variable 3-72 |
chrX_+_54834159 | 0.50 |
ENST00000375053.2 ENST00000347546.4 ENST00000375062.4 |
MAGED2 |
melanoma antigen family D, 2 |
chr2_+_5832799 | 0.50 |
ENST00000322002.3 |
SOX11 |
SRY (sex determining region Y)-box 11 |
chr17_+_61086917 | 0.50 |
ENST00000424789.2 ENST00000389520.4 |
TANC2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
chr10_+_5135981 | 0.49 |
ENST00000380554.3 |
AKR1C3 |
aldo-keto reductase family 1, member C3 |
chr4_-_143227088 | 0.49 |
ENST00000511838.1 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr12_+_26348429 | 0.49 |
ENST00000242729.2 |
SSPN |
sarcospan |
chr11_+_44117099 | 0.49 |
ENST00000533608.1 |
EXT2 |
exostosin glycosyltransferase 2 |
chr11_-_76381029 | 0.48 |
ENST00000407242.2 ENST00000421973.1 |
LRRC32 |
leucine rich repeat containing 32 |
chr11_-_102651343 | 0.48 |
ENST00000279441.4 ENST00000539681.1 |
MMP10 |
matrix metallopeptidase 10 (stromelysin 2) |
chr9_-_21994597 | 0.47 |
ENST00000579755.1 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr19_-_44031341 | 0.47 |
ENST00000600651.1 |
ETHE1 |
ethylmalonic encephalopathy 1 |
chrX_-_77150985 | 0.47 |
ENST00000358075.6 |
MAGT1 |
magnesium transporter 1 |
chr14_-_90798418 | 0.47 |
ENST00000354366.3 |
NRDE2 |
NRDE-2, necessary for RNA interference, domain containing |
chr1_+_169079823 | 0.47 |
ENST00000367813.3 |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr4_+_113739244 | 0.46 |
ENST00000503271.1 ENST00000503423.1 ENST00000506722.1 |
ANK2 |
ankyrin 2, neuronal |
chr8_-_66474884 | 0.46 |
ENST00000520902.1 |
CTD-3025N20.2 |
CTD-3025N20.2 |
chr1_+_158900568 | 0.46 |
ENST00000458222.1 |
PYHIN1 |
pyrin and HIN domain family, member 1 |
chr14_+_104029278 | 0.46 |
ENST00000472726.2 ENST00000409074.2 ENST00000440963.1 ENST00000556253.2 ENST00000247618.4 |
RP11-73M18.2 APOPT1 |
Kinesin light chain 1 apoptogenic 1, mitochondrial |
chr7_+_80267973 | 0.46 |
ENST00000394788.3 ENST00000447544.2 |
CD36 |
CD36 molecule (thrombospondin receptor) |
chr11_-_104972158 | 0.45 |
ENST00000598974.1 ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1 CARD16 CARD17 |
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr4_-_70826725 | 0.45 |
ENST00000353151.3 |
CSN2 |
casein beta |
chr4_-_156297949 | 0.45 |
ENST00000515654.1 |
MAP9 |
microtubule-associated protein 9 |
chr6_-_152639479 | 0.45 |
ENST00000356820.4 |
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
chr12_+_60083118 | 0.45 |
ENST00000261187.4 ENST00000543448.1 |
SLC16A7 |
solute carrier family 16 (monocarboxylate transporter), member 7 |
chrX_-_13835147 | 0.45 |
ENST00000493677.1 ENST00000355135.2 |
GPM6B |
glycoprotein M6B |
chr3_+_35722487 | 0.44 |
ENST00000441454.1 |
ARPP21 |
cAMP-regulated phosphoprotein, 21kDa |
chrX_-_68385354 | 0.44 |
ENST00000361478.1 |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
chr12_-_15038779 | 0.43 |
ENST00000228938.5 ENST00000539261.1 |
MGP |
matrix Gla protein |
chr22_+_23046750 | 0.43 |
ENST00000390307.2 |
IGLV3-22 |
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
chr3_+_101504200 | 0.42 |
ENST00000422132.1 |
NXPE3 |
neurexophilin and PC-esterase domain family, member 3 |
chr16_+_56970567 | 0.41 |
ENST00000563911.1 |
HERPUD1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
chr14_+_62229075 | 0.41 |
ENST00000216294.4 |
SNAPC1 |
small nuclear RNA activating complex, polypeptide 1, 43kDa |
chr1_-_163172625 | 0.41 |
ENST00000527988.1 ENST00000531476.1 ENST00000530507.1 |
RGS5 |
regulator of G-protein signaling 5 |
chr18_-_52989217 | 0.41 |
ENST00000570287.2 |
TCF4 |
transcription factor 4 |
chr2_-_211168332 | 0.41 |
ENST00000341685.4 |
MYL1 |
myosin, light chain 1, alkali; skeletal, fast |
chr17_+_19281034 | 0.40 |
ENST00000308406.5 ENST00000299612.7 |
MAPK7 |
mitogen-activated protein kinase 7 |
chr5_+_96211643 | 0.40 |
ENST00000437043.3 ENST00000510373.1 |
ERAP2 |
endoplasmic reticulum aminopeptidase 2 |
chr22_-_17702729 | 0.40 |
ENST00000449907.2 ENST00000441548.1 ENST00000399839.1 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
chr12_-_11062161 | 0.40 |
ENST00000390677.2 |
TAS2R13 |
taste receptor, type 2, member 13 |
chr2_-_152382500 | 0.39 |
ENST00000434685.1 |
NEB |
nebulin |
chr17_+_7788104 | 0.39 |
ENST00000380358.4 |
CHD3 |
chromodomain helicase DNA binding protein 3 |
chr20_-_34042558 | 0.39 |
ENST00000374372.1 |
GDF5 |
growth differentiation factor 5 |
chr9_-_95298314 | 0.39 |
ENST00000344604.5 ENST00000375540.1 |
ECM2 |
extracellular matrix protein 2, female organ and adipocyte specific |
chr2_+_172543919 | 0.39 |
ENST00000452242.1 ENST00000340296.4 |
DYNC1I2 |
dynein, cytoplasmic 1, intermediate chain 2 |
chr16_-_15474904 | 0.38 |
ENST00000534094.1 |
NPIPA5 |
nuclear pore complex interacting protein family, member A5 |
chr3_-_172241250 | 0.38 |
ENST00000420541.2 ENST00000241261.2 |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
chrX_-_68385274 | 0.38 |
ENST00000374584.3 ENST00000590146.1 |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
chr6_-_91296737 | 0.38 |
ENST00000369332.3 ENST00000369329.3 |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
chr9_-_23821842 | 0.38 |
ENST00000544538.1 |
ELAVL2 |
ELAV like neuron-specific RNA binding protein 2 |
chr10_-_79398250 | 0.38 |
ENST00000286627.5 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr1_-_21377447 | 0.37 |
ENST00000374937.3 ENST00000264211.8 |
EIF4G3 |
eukaryotic translation initiation factor 4 gamma, 3 |
chr3_+_38017264 | 0.37 |
ENST00000436654.1 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr2_+_102456277 | 0.37 |
ENST00000421882.1 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
chr15_+_40697988 | 0.37 |
ENST00000487418.2 ENST00000479013.2 |
IVD |
isovaleryl-CoA dehydrogenase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:1990523 | bone regeneration(GO:1990523) |
1.1 | 5.4 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
1.0 | 11.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 1.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.5 | 1.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.5 | 1.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 4.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 1.3 | GO:0071529 | cementum mineralization(GO:0071529) |
0.4 | 11.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 2.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.4 | 1.2 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.4 | 1.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.4 | 4.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 3.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 1.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 2.5 | GO:0072564 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.3 | 3.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 2.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 2.4 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 1.7 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.3 | 1.4 | GO:0097338 | response to clozapine(GO:0097338) |
0.3 | 0.8 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
0.2 | 1.0 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.2 | 1.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.6 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.2 | 0.6 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.2 | 1.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.6 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.2 | 0.6 | GO:1900081 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.2 | 1.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 4.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.6 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.2 | 2.0 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 1.2 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.2 | 0.5 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.5 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.2 | 1.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.9 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.2 | 0.5 | GO:1903487 | regulation of lactation(GO:1903487) |
0.2 | 1.8 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.3 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.1 | 0.5 | GO:0071306 | cellular response to vitamin E(GO:0071306) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 1.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.3 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.1 | 0.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 2.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 0.3 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.8 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 2.9 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 1.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.6 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.3 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 1.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) positive regulation of thymocyte apoptotic process(GO:0070245) oxidative stress-induced premature senescence(GO:0090403) oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 1.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.6 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.1 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.1 | 0.2 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 2.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.1 | 0.1 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.4 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.1 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.3 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.1 | 0.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.4 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.3 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.1 | GO:2000282 | regulation of cellular amino acid biosynthetic process(GO:2000282) |
0.1 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.2 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.2 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.0 | 1.1 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.4 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.2 | GO:0033133 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 1.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.0 | 0.0 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.4 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 1.0 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.4 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.6 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 1.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.0 | 0.8 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 4.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.0 | 0.3 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.3 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.0 | 0.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 1.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 1.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.3 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 2.3 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 4.5 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.2 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.5 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity(GO:0051090) |
0.0 | 0.0 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 0.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 11.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.6 | 3.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.4 | 6.6 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 1.1 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.3 | 2.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 4.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 3.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.6 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 0.6 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.2 | 1.0 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.6 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 4.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 1.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 1.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 2.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 0.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 1.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.2 | GO:0005657 | replication fork(GO:0005657) nuclear replication fork(GO:0043596) |
0.1 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.2 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 0.4 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 4.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 6.3 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 22.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 2.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 2.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 1.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.6 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 1.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 1.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) RISC-loading complex(GO:0070578) |
0.0 | 7.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 1.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.4 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0071546 | perinucleolar chromocenter(GO:0010370) pi-body(GO:0071546) |
0.0 | 0.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.6 | 4.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 1.8 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.4 | 2.5 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.3 | 3.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 1.2 | GO:0033265 | acetylcholinesterase activity(GO:0003990) choline binding(GO:0033265) |
0.2 | 3.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 6.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.2 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.2 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.2 | 0.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.2 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.6 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.2 | 0.6 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.2 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 15.3 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 4.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.2 | 1.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.1 | 0.5 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 2.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.5 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 1.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 1.0 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0032427 | GBD domain binding(GO:0032427) |
0.1 | 1.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 2.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.2 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 0.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 1.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.1 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 4.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.0 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 1.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 11.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 6.3 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 3.5 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 2.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:1901474 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.0 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.0 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 11.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 7.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 3.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 3.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 4.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 3.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 6.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 2.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 1.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 2.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.3 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 12.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 5.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 4.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 7.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 8.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 3.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |